This announcement is a separate document:
南京医药2024年度第一期中期票据发行结果公告
Announcement on the results of issuing the first issue of Nanjing Pharmaceutical's 2024 medium-term notes
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
07:36
The Study Times: Boosting the capital markets, the financing end needs to "separate false from true".
07:32
US media: The US Embassy in south korea advises Americans to avoid protest areas, calling south korea's situation 'still unstable'.
07:32
Intel is reportedly evaluating multiple potential CEO candidates, including former board members such as Chen Liwu and other external individuals.
INTEL-T0.00%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.